Overview
ITER Pharma is a Polish privately owned pharmaceutical company founded in 2025, specializing in bringing critical and niche medicinal products to hospitals, with a particular focus on generic medicines. Its portfolio includes medicines acting on the nervous system, antiviral medicines, and hospital antibiotics, supporting medicine security and access to affordable therapies.
Financials
Filing timeliness
The financial statement for 2025 was filed on time.
- 202527/05/2026
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Generic medicines
- Hospital medicines
- Antibiotics
- Antiviral medicines
- Medicines acting on the nervous system
Authorized Representatives
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Kamil Garberaage 36 | 90 | $1,215.56 | 90% |
Katarzyna Adrianna Gutowskaage 34 | 10 | $135.06 | 10% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-07-03.
25 1090 2835 0000 0001 6279 0224
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Optimedussp. z o.o. | $1.00 | optimedus.pl | ||
| Agri Starsp. z o.o. | $0.29 | maskforyou.pl | ||
| Novaovasp. z o.o. | $0.16 | novaova.pl |
FAQ
Last updated: 2026-05-27